공막 내 삽입한 생체분해성 고분자 매트릭스를 이용한 스테로이드 지속 방출 방법의 개발 = The Development of Biodegradable Intrascleral Implant for Slow Releasing of Triamcinolone Acetonide

다국어 초록 (Multilingual Abstract)

Purpose: In order to treat inflammatory and proliferative disorders of the posterior segment of the eye, the authors evaluated the use of a biodegradable intrascleral implant for slow release of triamcinolone acetonide (TA). Methods: The intrascleral implant (1 mm thick and 3 mm in diameter) was made of alginic acid and PLA (poly (D,L-lactide)) containing 4 mg of TA. In vitro release of TA was evaluated by HPLC. To evaluate in vivo release of TA, the implant was placed into a scleral pocket in 18 rabbit eyes and the concentrations of TA in the aqueous humor, vitreous, and retina-choroid-sclera were measured by HPLC at 1, 2, 4, 8, and 12 weeks after implantation. The toxicity and biocompatibility of the implant were evaluated by slit lamp examination, IOP, electroretinogram, and light microscopy. Results: In vitro study demonstrated that the implant released TA in controlled manner for at least 8 months. The TA detected in the vitreous after 8 to 12 weeks and was not detected in retina-choroid-sclera at 8 weeks after implantation. The TA was not detected in aqueous humor. No significant toxicity to the retina was observed. Conclusions: These results suggest that the intrascleral implant of TA could be a promising system for the delivery of steroids to the posterior segment of eye in cases of inflammatory or proliferative disorders of posterior segment.

참고문헌 (Reference)

1 "effects of age" 1995

2 "Treatment of cytomegalovirus retinitis with an intraocular sustained-release gancyclovir implant - a randomized cotrolled clinical-trial" 112 : 1531-9, 1994

3 "The clearance of intravitreal triamcinolone acetonide" 93 : 415-7, 1982

4 "Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis" 110 : 188-95, 1992

5 "Scleral plug of biodegradable polymers containing tacrolimus(FK 506)for experimental uveitis" 44 : 4845-7, 2003

6 "Release of triamcinolone from mucoadhesive polymer composed of chitosan and poly(acrylic acid)in vitro" 23 : 1411-6, 2002

7 "Physico- chemical determinants of drug diffusion across the conjunctiva,sclera,and cornea" 76 : 583-6, 1987

8 "Pharmacokinetics and toxicity of an intravitreal devices providing sustained-release of cyclosporine and dexamethason" 35 : 190-6, 1994

9 "Ocular drug delivery conventional ocular formulations" 16 : 39-43, 1995

10 "Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device" 44 : 2702-7, 2003

11 "Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection" 110 : 681-6, 2003

12 "Importance of the noncorneal absorption route in topical ophthalmic drug delivery" 26 : 584-7, 1985

13 "Human sclera:thickness and surface area" 125 : 237-41, 1998

14 "Fiber matrix model of sclera and corneal stroma for drug delivery to the eye" 44 : 214-25, 1998

15 "Diffusion of high molecular weight compounds through sclera" 41 : 1181-5, 2000

16 "Determination of methyl paraben,propylparaban,triamcinolone acetonide and its degradation product in a topical cream by HPLC" 376 : 440-3, 2003

17 "Clearance of triamcinolone from vitreous" 103 : 1567-98, 1985

18 "Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits" 14 : 474-7, 1995

19 "Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate" 44 : 740-4, 2003

20 "Automated coupling of capillary-HPLC to matrix-assisted laser desorption/ionization mass spectrometry for the analysis of small molecules utilizing a respective matrix" 376 : 773-9, 2003

21 "Acute endophthalmitis following intravitreal triamcinolone acetonide injection" 136 : 791-6, 2003